America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Durham, NC
  4. Glioblastoma Foundation

Glioblastoma Foundation

Glioblastoma Foundation is ranked among medical research organizations in Durham, NC, with an America's Best Score of 80 out of 100, based on its 2024 Form 990.

  • Durham, NC
  • Tax-exempt since 2016
  • EIN: 81-2849764
glioblastomafoundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
80OF 100 Ranked in Durham Medical Research How this score is calculated

Organization summary

Glioblastoma Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H30). Contributions are tax-deductible.

2451 Croasdaile Farm Pkwy Ste 109, Durham, NC 27705-1466

Among the 6 scored medical research organizations in Durham, Glioblastoma Foundation holds 20.7 months of operating reserves (peer median 21.6 months), runs a typical yearly surplus of 46.4% (peers: surplus of 1.4%), and has grown spending 37.6% a year (peers: grown spending 29.0% a year).

In fiscal year 2024 it reported $2,055,218 in revenue and $1,833,664 in expenses, with contributions making up 95.6% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

The Glioblastoma Foundation is dedicated to finding a cure for glioblastoma by funding research and drug development, supporting patients and families, and raising national awareness of this devastating brain cancer. Through these integrated programs, the foundation accelerates scientific discovery, empowers patients with information and resources, and educates the public about the urgent need for better treatments and improved outcomes.

Largest programs · fiscal year 2024

  • Research and drug development:in 2024, the Glioblastoma Foundation advanced its research mission by acquiring lisavanbulin, a promising targeted therapy from basilea pharmaceutica, for further clinical development in glioblastoma. This acquisition marked a critical step toward bringing patients new, more effective treatments. The foundation also supported investigator-initiated research on molecul… Read more

    Research and drug development:in 2024, the Glioblastoma Foundation advanced its research mission by acquiring lisavanbulin, a promising targeted therapy from basilea pharmaceutica, for further clinical development in glioblastoma. This acquisition marked a critical step toward bringing patients new, more effective treatments. The foundation also supported investigator-initiated research on molecular characterization and functional precision oncology. Additionally, the foundation established gliolab, a clia-registered genomic laboratory that will provide state-of-the-art testing to accelerate discovery of targeted therapies based on each tumor's genomic and epigenomic profile.

    $527,251 spent · 33.3% of program spending
  • Patient support and education:throughout 2024, the foundation provided support services for glioblastoma patients and caregivers nationwide, including personalized clinical-trial matching, professionally led virtual support groups, and educational resources on treatment options and emerging research. These programs empowered patients to make informed care decisions and fostered a sense of communit… Read more

    Patient support and education:throughout 2024, the foundation provided support services for glioblastoma patients and caregivers nationwide, including personalized clinical-trial matching, professionally led virtual support groups, and educational resources on treatment options and emerging research. These programs empowered patients to make informed care decisions and fostered a sense of community among families affected by this rare disease. Hundreds of patients and caregivers benefited from these free services during the year.

    $527,251 spent · 33.3% of program spending
  • Public awareness and advocacy:the foundation led nationwide efforts to raise awareness and advocacy for those affected by glioblastoma. In 2024, it organized glioblastoma awareness day and continued the voices of glioblastoma podcast while planning to expand the series in future years to feature additional patient, caregiver, and scientist perspectives. The foundation also partnered with events su… Read more

    Public awareness and advocacy:the foundation led nationwide efforts to raise awareness and advocacy for those affected by glioblastoma. In 2024, it organized glioblastoma awareness day and continued the voices of glioblastoma podcast while planning to expand the series in future years to feature additional patient, caregiver, and scientist perspectives. The foundation also partnered with events such as the los angeles marathon to increase public understanding and support for research. These initiatives educated thousands and inspired hope within the glioblastoma community.

    $527,250 spent · 33.3% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 86¢ went to programs, 13¢ to management and 1¢ to fundraising.

  • Programs $1,581,752
  • Management $237,982
  • Fundraising $13,930

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score80 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves20.7 mo; 4.0 mo in cash14.4 / 25
Financial balance (median margin)+46.4%17.5 / 20
Transparency4 full 990s, latest TY202420 / 20
Program growth+37.6% / yr15 / 15
Track record10 years4 / 10
Debt load13.6% of assets9.3 / 10
Total80.2 → 80
Spending on programs
Not scored; America's Best needs 65%+
86%Meets

Compared with Durham peers

MeasureThis organizationPeer median
Operating reserves20.7 mo21.6 mo
Typical margin+46.4%+1.4%
Spending growth+37.6% / yr+29.0% / yr
Debt load13.6%9.0%

Peers: the 6 Durham medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$2,055,218Fiscal year 20242021: $1,253,57420212022: $1,471,55020222023: $1,699,78420232024: $2,055,2182024
Expenses$1,833,664Fiscal year 20242021: $703,35120212022: $853,57820222023: $1,411,49220232024: $1,833,6642024
Total assets$3,662,658Fiscal year 20242021: $1,523,93620212022: $1,781,39920222023: $2,482,02620232024: $3,662,6582024
Total liabilities$496,171Fiscal year 20242021: $020212022: $020222023: $020232024: $496,1712024
Fiscal year ending December 2024
Revenue$2,055,218
Expenses$1,833,664
Net income$221,554
Net assets$3,166,487

Notable sources of revenue

Percent of total revenue
Contributions$1,964,537
Program services$0
Investment income$2,803
Other (net)$87,878

Assets / debt

Total assets$3,662,658
Total liabilities$496,171
Net assets$3,166,487

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$1,699,784
Expenses$1,411,492
Net income$288,292
Net assets$2,482,026

Notable sources of revenue

Percent of total revenue
Contributions$1,691,690
Program services$0
Investment income$8,094
Other (net)$0

Assets / debt

Total assets$2,482,026
Total liabilities$0
Net assets$2,482,026

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$1,471,550
Expenses$853,578
Net income$617,972
Net assets$1,781,399

Notable sources of revenue

Percent of total revenue
Contributions$1,513,382
Program services$0
Investment income$14,333
Other (net)−$56,165

Assets / debt

Total assets$1,781,399
Total liabilities$0
Net assets$1,781,399

Compensation

Officers and key employees$192,826
Share of expenses22.6%
Fiscal year ending December 2021
Revenue$1,253,574
Expenses$703,351
Net income$550,223
Net assets$1,523,936

Notable sources of revenue

Percent of total revenue
Contributions$1,302,093
Program services$0
Investment income$9,185
Other (net)−$57,704

Assets / debt

Total assets$1,523,936
Total liabilities$0
Net assets$1,523,936

Compensation

Officers and key employees$180,000
Share of expenses25.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?